sch13ga_021110.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549

SCHEDULE 13G/A
Amendment No. 1

Under the Securities Exchange Act of 1934*


China Cord Blood Corporation
(Name of Issuer)
 
Common Stock, par value $0.0001 per share
(Title of Class of Securities)
 
G21107100
(CUSIP Number)
 
December 31, 2009
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

[   ]                 Rule 13d-1(b)
[X]                 Rule 13d-1(c)
[   ]                 Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes).
 

 

 


CUSIP No.
  G21107100

 
1
 
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON  (entities only)
Jayhawk China Fund (Cayman), Ltd. (98-0170144)
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)  [   ]
(b)  [X]
 
3
 
SEC USE ONLY
 
4
 
CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
 
 
NUMBER OF SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH:
 
5
 
SOLE VOTING POWER
0
 
6
 
SHARED VOTING POWER
3,395,321*
 
7
 
SOLE DISPOSITIVE POWER
0
 
8
 
SHARED DISPOSITIVE POWER
3,395,321*
 
9
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,395,321*  (see Item 4)
 
10
 
CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES (See Instructions)  [   ]
Not Applicable
 
11
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.1%**
 
12
 
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
 
*  Includes 3,192,321 shares of common stock, par value $0.0001 per share, and 203,000 warrants to purchase common stock that are exercisable within 60 days.
**  Based on 66,182,726 outstanding shares of common stock, par value $0.0001 per share, as reported by  China Cord Blood Corporation on its Rule 424B3 filing made on November 24, 2009.



 
Page 1 of 12 Pages

 

CUSIP No.
G21107100


 
1
 
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON  (entities only)
Jayhawk Capital Management, L.L.C. (48-1172612)
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)  [   ]
(b)  [X]
 
3
 
SEC USE ONLY
 
4
 
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
 
 
NUMBER OF SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH:
 
5
 
SOLE VOTING POWER
0
 
6
 
SHARED VOTING POWER
3,395,321*
 
7
 
SOLE DISPOSITIVE POWER
0
 
8
 
SHARED DISPOSITIVE POWER
3,395,321*
 
9
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,395,321*  (see Item 4)
 
10
 
CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES (See Instructions)  [   ]
Not Applicable
 
11
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.1%**
 
12
 
OO
 
*  Includes 3,192,321 shares of common stock, par value $0.0001 per share, held by Jayhawk China Fund (Cayman), Ltd. and 203,000 warrants to purchase common stock that are exercisable within 60 days held by Jayhawk China Fund (Cayman), Ltd.
**  Based on 66,182,726 outstanding shares of common stock, par value $0.0001 per share, as reported by  China Cord Blood Corporation on its Rule 424B3 filing made on November 24, 2009.

 
 

 
Page 2 of 12 Pages

 


CUSIP No.
G21107100
 
1
 
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON  (entities only)
Jayhawk Private Equity Fund II, L.P. (26-1692972)
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)  [   ]
(b)  [X]
 
3
 
SEC USE ONLY
 
4
 
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
 
 
NUMBER OF SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH:
:
 
5
 
SOLE VOTING POWER
0
 
6
 
SHARED VOTING POWER
8,133,787*
 
7
 
SOLE DISPOSITIVE POWER
0
 
8
 
SHARED DISPOSITIVE POWER
8,133,787*
 
9
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
8,133,787*  (see Item 4)
 
10
 
CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES (See Instructions)  [   ]
Not Applicable
 
11
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
11.0%**
 
12
 
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
 
*  Includes 533,970 shares of common stock, par value $0.0001 per share, and 7,599,817 warrants to purchase common stock that are exercisable within 60 days.
**  Based on 66,182,726 outstanding shares of common stock, par value $0.0001 per share, as reported by  China Cord Blood Corporation on its Rule 424B3 filing made on November 24, 2009.



 
Page 3 of 12 Pages

 


CUSIP No.
G21107100

 
1
 
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON  (entities only)
Jayhawk Private Equity GP II, L.P. (26-1692915)
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)  [   ]
(b)  [X]
 
3
 
SEC USE ONLY
 
4
 
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
 
 
NUMBER OF SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH:
 
5
 
SOLE VOTING POWER
0
 
6
 
SHARED VOTING POWER
8,133,787*
 
7
 
SOLE DISPOSITIVE POWER
0
 
8
 
SHARED DISPOSITIVE POWER
8,133,787*
 
9
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
8,133,787*  (see Item 4)
 
10
 
CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES (See Instructions)  [   ]
Not Applicable
 
11
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
11.0%**
 
12
 
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
 
*  Includes 533,970 shares of common stock, par value $0.0001 per share, and 7,599,817 warrants to purchase common stock that are exercisable within 60 days held by Jayhawk Private Equity Fund II, L.P.
**  Based on 66,182,726 outstanding shares of common stock, par value $0.0001 per share, as reported by  China Cord Blood Corporation on its Rule 424B3 filing made on November 24, 2009.


 
Page 4 of 12 Pages

 


CUSIP No.
G21107100

 
1
 
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON  (entities only)
Jayhawk Private Equity, LLC (26-1692786)
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)  [   ]
(b)  [X]
 
3
 
SEC USE ONLY
 
4
 
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
 
 
NUMBER OF SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH:
:
 
5
 
SOLE VOTING POWER
0
 
6
 
SHARED VOTING POWER
8,133,787*
 
7
 
SOLE DISPOSITIVE POWER
0
 
8
 
SHARED DISPOSITIVE POWER
8,133,787*
 
9
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
8,133,787*  (see Item 4)
 
10
 
CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES (See Instructions)  [   ]
Not Applicable
 
11
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
11.0%**
 
12
 
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
OO
 
*  Includes 533,970 shares of common stock, par value $0.0001 per share, and 7,599,817 warrants to purchase common stock that are exercisable within 60 days held by Jayhawk Private Equity Fund II, L.P.
**  Based on 66,182,726 outstanding shares of common stock, par value $0.0001 per share, as reported by  China Cord Blood Corporation on its Rule 424B3 filing made on November 24, 2009.
 

 
 

 
Page 5 of 12 Pages

 

CUSIP No.                        G21107100


 
1
 
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON  (entities only)
Kent C. McCarthy
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)  [   ]
(b)  [X]
 
3
 
SEC USE ONLY
 
4
 
CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
 
 
NUMBER OF SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH:
 
5
 
SOLE VOTING POWER
0
 
6
 
SHARED VOTING POWER
11,529,108*
 
7
 
SOLE DISPOSITIVE POWER
0
 
8
 
SHARED DISPOSITIVE POWER
11,529,108*
 
9
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11,529,108*  (see Item 4)
 
10
 
CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES (See Instructions)  [   ]
Not Applicable
 
11
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
15.6%**
 
12
 
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
 
*  Includes 3,192,321shares of common stock, par value $0.0001 per share and 203,000 warrants to purchase common stock that are exercisable within 60 days held by Jayhawk China Fund (Cayman), Ltd. and 533,970 shares of common stock, par value $0.0001 per share, and 7,599,817 warrants to purchase common stock that are exercisable within 60 days held by the Jayhawk Private Equity Fund II, L.P.
**  Based on 66,182,726 outstanding shares of common stock, par value $0.0001 per share, as reported by  China Cord Blood Corporation on its Rule 424B3 filing made on November 24, 2009.


 
Page 6 of 12 Pages

 

Item 2(b)
Address of Principal Business Office or, if None, Residence:

The principal business address of Jayhawk China Fund (Cayman), Ltd., Jayhawk Capital Management, L.L.C., Jayhawk Private Equity Fund II, L.P., Jayhawk Private Equity GP II, L.P., Jayhawk Private Equity, LLC, and Kent C. McCarthy is 930 Tahoe Blvd., 802-281, Incline Village, NV, 89451.

Item 4
Ownership:

The information below is as of the date of December 31, 2009.

(a)  Amount beneficially owned:
1.  Jayhawk China Fund (Cayman), Ltd.: 3,395,321*
2.  Jayhawk Capital Management, L.L.C.: 3,395,321*
3.  Jayhawk Private Equity Fund II, L.P.: 8,133,787**
4.  Jayhawk Private Equity GP, L.P.: 8,133,787**
5.  Jayhawk Private Equity, LLC: 8,133,787**
6.  Kent C. McCarthy: 11,529,108***

(b)  Percent of class:
1.  Jayhawk China Fund (Cayman), Ltd.: 5.1%
2.  Jayhawk Capital Management, L.L.C.: 5.1%
3.  Jayhawk Private Equity Fund II, L.P.: 11.0%
4.  Jayhawk Private Equity GP, L.P.: 11.0%
5.  Jayhawk Private Equity, LLC: 11.0%
6.  Kent C. McCarthy: 15.6%

Percent of class is based on 66,182,726 outstanding shares of common stock, par value $0.0001 per share, as reported by  China Cord Blood Corporation on its Rule 424B3 filing made filed on November 24, 2009.

(c)  Number of shares as to which the person has:

(i)    Sole power to vote or to direct the vote:
1.  Jayhawk China Fund (Cayman), Ltd.: 0
2.  Jayhawk Capital Management, L.L.C.: 0
3.  Jayhawk Private Equity Fund II, L.P.: 0
4.  Jayhawk Private Equity GP, L.P.: 0
5.  Jayhawk Private Equity, LLC: 0
6.  Kent C. McCarthy: 0

(ii)    Shared power to vote or direct the vote:                                                                      
1.  Jayhawk China Fund (Cayman), Ltd.: 3,395,321*
2.  Jayhawk Capital Management, L.L.C.: 3,395,321*
3.  Jayhawk Private Equity Fund II, L.P.: 8,133,787**
4.  Jayhawk Private Equity GP, L.P.: 8,133,787**
5.  Jayhawk Private Equity, LLC: 8,133,787**
6.  Kent C. McCarthy: 11,529,108***

(iii)   Sole power to dispose or to direct the disposition of:
1.  Jayhawk China Fund (Cayman), Ltd.: 0
2.  Jayhawk Capital Management, L.L.C.: 0
3.  Jayhawk Private Equity Fund II, L.P.: 0
4.  Jayhawk Private Equity GP, L.P.: 0
5.  Jayhawk Private Equity, LLC: 0
6.  Kent C. McCarthy: 0
 
 (iv)  Shared power to dispose or to direct the disposition of:
1.  Jayhawk China Fund (Cayman), Ltd.: 3,395,321*
2.  Jayhawk Capital Management, L.L.C.: 3,395,321*
3.  Jayhawk Private Equity Fund II, L.P.: 8,133,787**
4.  Jayhawk Private Equity GP, L.P.: 8,133,787**
5.  Jayhawk Private Equity, LLC: 8,133,787**
6.  Kent C. McCarthy: 11,529,108***

 
Page 7 of 12 Pages

 


*  Includes 3,192,321 shares of common stock, par value $0.0001 per share, and 203,000 warrants to purchase common stock that are exercisable within 60 days held by Jayhawk China Fund (Cayman), Ltd.

**  Includes 533,970 shares of common stock, par value $0.0001 per share, and 7,599,817 warrants to purchase common stock that are exercisable within 60 days held by Jayhawk Private Equity Fund II, L.P.

***  Includes 3,192,321shares of common stock, par value $0.0001 per share, and 203,000 warrants to purchase common stock that are exercisable within 60 days held by Jayhawk China Fund (Cayman), Ltd. and 533,970 shares of common stock, par value $0.0001 per share, and 7,599,817 warrants to purchase common stock that are exercisable within 60 days held by the Jayhawk Private Equity Fund II, L.P.
 

Item 10
Certification:

By signing below each party certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
 
 

 
Page 8 of 12 Pages

 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, the parties below certify that the information set forth in this statement is true, complete and correct.

Dated:
February 16, 2010
 
 
     
       
   
/s/ Kent C. McCarthy 
 
   
Kent C. McCarthy
 
       
       

 
Jayhawk Capital Management, L.L.C.
 
       
 
By:
/s/ Kent C. McCarthy  
 
   
Name: Kent C. McCarthy
 
   
Title:   Manager
 
       
       
 
 
Jayhawk Private Equity, L.L.C.
 
       
 
By:
/s/ Kent C. McCarthy  
 
   
Name:  Kent C. McCarthy
 
   
Title:    Manager
 
       
       
 
 
Jayhawk Private Equity GP II, L.P.
 
       
 
By:
Jayhawk Private Equity, L.L.C.
Its general partner
 
/s/ Kent C. McCarthy 
 
   
Name:  Kent C. McCarthy
 
   
Title:    Manager
 
       
       
 
 
Jayhawk Private Equity Fund II, L.P.
 
       
 
By:
Jayhawk Private Equity GP II, L.P.
Its general partner
 
/s/ Kent C. McCarthy 
 
   
Name: Kent C. McCarthy
 
   
Title:   Manager of Jayhawk Private Equity, L.L.C., the General Partner of Jayhawk Private Equity GP II, L.P.
 
       
       
 
Page 9 of 12 Pages

 
Jayhawk China Fund (Cayman), Ltd.
 
       
 
By:
Jayhawk Capital Management, L.L.C.,
Its Investment Manager
 
/s/ Kent C. McCarthy 
 
   
Name: Kent McCarthy
 
   
Title:   Manager
 

 
Page 10 of 12 Pages

 

 
Exhibit A
 
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13G
 
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock, par value $0.0001 per share, of China Cord Blood Corporation, and further agree that this Agreement be included as an exhibit to such filings.

In evidence whereof, the undersigned have caused this Agreement to be executed on their behalf this 10th day of August, 2009.
 
 
     
       
   
/s/ Kent C. McCarthy  
 
   
Kent C. McCarthy
 
       
       

 
Jayhawk Capital Management, L.L.C.
 
       
 
By:
/s/ Kent C. McCarthy  
 
   
Name: Kent C. McCarthy
 
   
Title:   Manager
 
       
       
 
 
Jayhawk Private Equity, L.L.C.
 
       
 
By:
/s/ Kent C. McCarthy  
 
   
Name:  Kent C. McCarthy
 
   
Title:    Manager
 
       
       
 
 
Jayhawk Private Equity GP II, L.P.
 
       
 
By:
Jayhawk Private Equity, L.L.C.
Its general partner
 
/s/ Kent C. McCarthy 
 
   
Name:  Kent C. McCarthy
 
   
Title:    Manager
 
       
       
 
 
Jayhawk Private Equity Fund II, L.P.
 
       
 
By:
Jayhawk Private Equity GP II, L.P.
Its general partner
 
/s/ Kent C. McCarthy 
 
   
Name: Kent C. McCarthy
 
   
Title:   Manager of Jayhawk Private Equity, L.L.C., the General Partner of Jayhawk Private Equity GP II, L.P.
 
       
 
 
Page 11 of 12 Pages

 
Jayhawk China Fund (Cayman), Ltd.
 
       
 
By:
Jayhawk Capital Management, L.L.C.,
Its Investment Manager
 
/s/ Kent C. McCarthy 
 
   
Name: Kent McCarthy
 
   
Title:   Manager 
 
       
Page 12 of 12 Pages